Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

Meta’s new rules on deepfakes and AI

Published

on

Meta announced major changes to its policies on digitally created and altered media, ahead of U.S. elections poised to test its ability to police deceptive content.

The social media giant will start applying “Made with AI” labels in May to AI-generated videos, images and audio posted on its platforms, expanding a policy that previously addressed only a narrow slice of doctored videos, Vice President of Content Policy Monika Bickert said in a blog post.

Bickert said Meta would also apply separate and more prominent labels to digitally altered media that poses a “particularly high risk of materially deceiving the public on a matter of importance,” regardless of whether the content was created using AI or other tools.

The new approach will shift the company’s treatment of manipulated content. It will move from one focused on removing a limited set of posts toward one that keeps the content up while providing viewers with information about how it was made.

Meta previously announced a scheme to detect images made using other companies’ generative AI tools using invisible markers built into the files, but did not give a start date at the time.

Posted content

A company spokesperson told Reuters the new labeling approach would apply to content posted on Meta’s Facebook, Instagram and Threads services.

Its other services, including WhatsApp and Quest virtual reality headsets, are covered by different rules.

Meta will begin applying the more prominent “high-risk” labels immediately, the spokesperson said.

The changes come months before a U.S. presidential election in November that tech researchers warn may be transformed by new generative AI technologies.

A deepfake of former U.S. President Barak Obama.

Political campaigns have already begun deploying AI tools in places like Indonesia, pushing the boundaries of guidelines issued by providers like Meta and generative AI market leader OpenAI.
In February, Meta’s oversight board called the company’s existing rules on manipulated media “incoherent” after reviewing a video of U.S. President Joe Biden posted on Facebook last year that altered real footage to wrongfully suggest he had behaved inappropriately.

The footage was permitted to stay up, as Meta’s existing “manipulated media” policy bars misleadingly altered videos only if they were produced by artificial intelligence or if they make people appear to say words they never actually said.

The board said the policy should also apply to non-AI content, which is “not necessarily any less misleading” than content generated by AI, as well as to audio-only content and videos depicting people doing things they never actually did.

Continue Reading

News

Does American media have TikTok bias?

Published

on

While the fate of TikTok remains uncertain in the U.S.—there is no shortage of possibilities.

Euro Bloch is a comprehensive program designed to highlight the breadth of topics and issues within the EU political landscape. It offers insightful analysis within the evolving framework of relations between the European Union and Australia/Asia-Pacific region. Hosted by Natanael Bloch.

Next month’s EU elections are looming, with the far-right gaining traction. In this episode, Natanael is joined by Professor Bruce Wilson, Director of EU Centre of Excellence at RMIT University. #EURO BLOCH

Continue Reading

News

Will the U.S. approve MDMA therapy?

Published

on

MDMA is a drug commonly known as molly or ecstasy.

Some medical professionals say it can be helpful for people with post-traumatic stress disorder — which is why a group has been fighting to get MDMA legalized as a prescription drug.

Currently, the U.S. Food and Drug Administration is reviewing an application to use MDMA to treat PTSD. The agency is expected to announce its ruling as soon as August.

Anna Silman, a features correspondent with Business Insider joins Veronica Dudo to discuss. #IN AMERICA TODAY #trending #drugs #MDMA #MDMATherapy #business #pharmaceutical

Continue Reading

Trending Now